Japan's national medical insurance system was given the go-ahead on Wednesday to cover leukemia treatment using expensive Kymriah from Swiss drugmaker Novartis.
A Saga University research team is aiming to start in summer of this year at the earliest a clinical study involving the transplantation of blood vessels made with a three-dimensional bioprinter into patients receiving hemodialysis.
Science has Dr. Masayo Takahashi’s mother to thank, in a way, for some of the most notable developments in regenerative medicine using stem cells.
A Japanese team reported Thursday that five patients with a severe eye disease were doing well after they received in 2017 the world’s first transplant surgeries using induced pluripotent stem cells, known as iPS cells, from donors.
As the risk of cancer increases among the country’s aging population, immunologist Tasuku Honjo is pinning his hopes on cancer treatments that shift the approach from traditional methods directly targeting cancer cells to ones that stimulate the body’s immune system to fight the disease.
A medicine that encourages nerve cell regeneration can help improve mobility functions of spinal cord injury patients in their acute period, including those who are completely paralyzed, a research team led by a Keio University professor said on Thursday.
Drugmakers look to apply advanced technologies used to treat cancer and other diseases toward combating seasonal allergies, a market segment set to skyrocket as climate change expands the range of affected populations worldwide.
NTT Docomo Inc. and Tohoku University announced plans to jointly develop artificial intelligence technology that can detect gum disease by analyzing photographs taken on smartphones.
The Economy, Trade and Industry Ministry is supporting the development of an artificial intelligence program that helps diabetics improve their dietary and other daily habits to prevent their condition from becoming severe, sources have said.
Pharmacists will likely be allowed to hold online consultations with patients about their medication from April 2020, reflecting the rising demand for in-home medical care among the country’s rapidly graying population, officials said Tuesday.